26 related articles for article (PubMed ID: 38560761)
1. Visible and Red Light-Triggered Anticancer Profile of a Ferrocene-Re(I)-Tricarbonyl Conjugate: Experimental and Theoretical Studies.
Kushwaha R; Upadhyay A; Peters S; Yadav AK; Mishra A; Bera A; Sadhukhan T; Banerjee S
Langmuir; 2024 Jun; 40(23):12226-12238. PubMed ID: 38814099
[TBL] [Abstract][Full Text] [Related]
2. Near-Infrared Absorbing Aza-BODIPY Dyes for Optoelectronic Applications.
Pinjari D; Patil Y; Misra R
Chem Asian J; 2024 May; ():e202400167. PubMed ID: 38733151
[TBL] [Abstract][Full Text] [Related]
3. β-Galactosidase-Triggered Photodynamic Elimination of Senescent Cells with a Boron Dipyrromethene-Based Photosensitizer.
Chu JCH; Escriche-Navarro B; Xiong J; García-Fernández A; Martínez-Máñez R; Ng DKP
Adv Sci (Weinh); 2024 Jun; ():e2401012. PubMed ID: 38884205
[TBL] [Abstract][Full Text] [Related]
4. Towards efficient Ir(III) anticancer photodynamic therapy agents by extending π-conjugation on N^N ligands.
Sanz-Villafruela J; Bermejo-Casadesús C; Martínez-Alonso M; Moro A; Lima JC; Massaguer A; Espino G
Dalton Trans; 2024 Jun; ():. PubMed ID: 38899369
[TBL] [Abstract][Full Text] [Related]
5. Shedding light on imaging safety: Decoding the origin of photocytotoxicity in RhB-assisted fluorescence imaging.
Luo C; Yao W; Zhang H; Jia M; Lim CK; Hu W
J Biophotonics; 2024 Jun; 17(6):e202400049. PubMed ID: 38634340
[TBL] [Abstract][Full Text] [Related]
6. Exploring BODIPY Derivatives as Singlet Oxygen Photosensitizers for PDT.
Prieto-Montero R; Prieto-Castañeda A; Sola-Llano R; Agarrabeitia AR; García-Fresnadillo D; López-Arbeloa I; Villanueva A; Ortiz MJ; de la Moya S; Martínez-Martínez V
Photochem Photobiol; 2020 May; 96(3):458-477. PubMed ID: 32077486
[TBL] [Abstract][Full Text] [Related]
7. Lysosome directed red light photodynamic therapy using glycosylated iron-(III) conjugates of boron-dipyrromethene.
Sahoo S; Pathak S; Kumar A; Nandi D; Chakravarty AR
J Inorg Biochem; 2023 Jul; 244():112226. PubMed ID: 37105008
[TBL] [Abstract][Full Text] [Related]
8. Cobalt(III) Complexes for Light-Activated Delivery of Acetylacetonate-BODIPY, Cellular Imaging, and Photodynamic Therapy.
Jana A; Kundu P; Paul S; Kondaiah P; Chakravarty AR
Inorg Chem; 2022 May; 61(18):6837-6851. PubMed ID: 35471858
[TBL] [Abstract][Full Text] [Related]
9. Pyriplatin-Boron-Dipyrromethene Conjugates for Imaging and Mitochondria-Targeted Photodynamic Therapy.
Raza MK; Gautam S; Howlader P; Bhattacharyya A; Kondaiah P; Chakravarty AR
Inorg Chem; 2018 Nov; 57(22):14374-14385. PubMed ID: 30376306
[TBL] [Abstract][Full Text] [Related]
10. Ruthenium(II) Conjugates of Boron-Dipyrromethene and Biotin for Targeted Photodynamic Therapy in Red Light.
Paul S; Kundu P; Bhattacharyya U; Garai A; Maji RC; Kondaiah P; Chakravarty AR
Inorg Chem; 2020 Jan; 59(1):913-924. PubMed ID: 31825210
[TBL] [Abstract][Full Text] [Related]
11. Biotin and boron-dipyrromethene-tagged platinum(IV) prodrug for cellular imaging and mito-targeted photocytotoxicity in red light.
Bera A; Nepalia A; Upadhyay A; Kumar Saini D; Chakravarty AR
Dalton Trans; 2023 Sep; 52(37):13339-13350. PubMed ID: 37671587
[TBL] [Abstract][Full Text] [Related]
12. Photodynamic Therapy with Targeted Release of Boron-Dipyrromethene Dye from Cobalt(III) Prodrugs in Red Light.
Jana A; Sahoo S; Paul S; Sahoo S; Jayabaskaran C; Chakravarty AR
Inorg Chem; 2024 Apr; 63(15):6822-6835. PubMed ID: 38560761
[TBL] [Abstract][Full Text] [Related]
13. Boron Dipyrromethene Nano-Photosensitizers for Anticancer Phototherapies.
Sun W; Zhao X; Fan J; Du J; Peng X
Small; 2019 Aug; 15(32):e1804927. PubMed ID: 30785670
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
